Quality of Life before and after Sleeve Gastrectomy in Lebanese Population

Introduction. Obesity is increasing worldwide and in Lebanon with a negative impact on the quality of life. The primary objective of this study is to measure the quality of life in obese subjects before and after bariatric surgery, depending on age, sex, and degree of weight loss. A secondary objective is to determine the impact of bariatric surgery on comorbidities associated with obesity. Materials and methods. Patients undergoing laparoscopic sleeve gastrectomy for BMI ≥ 30 kg/m2 between August 2016 and April 2017 were included. Participants completed the Moorehead-Ardelt Quality of Life Questionnaire II (MA II) prior to operation and one year after. Statistical analysis was carried out using SPSS statistics version 20.0. Results. 75 patients participated in the study. The majority were women (75%), and the mean age was 36.3 years. The mean weight loss was 36.57 kg (16–76). Initially, the total MA II score was −0.33 ± 0.93. Postoperatively, it increased to 1.68 ± 0.62 (p≤0.001). All MA II parameters improved after surgery (p≤0.001), but this improvement was independent of age and sex. Improvement in self-esteem, physical activity, work performance, and sexual pleasure was influenced by the degree of weight loss (p≤0.001). All comorbidities associated with obesity regressed significantly after sleeve gastrectomy (p<0.05) with the exception of gastroesophageal reflux and varicose veins of the lower limbs. Conclusion. Sleeve gastrectomy improves quality of life and allows reduction of comorbidities.

Download Full-text

QUALITY OF LIFE AFTER LAPAROSCOPIC SLEEVE GASTRECTOMY USİNG BAROS SYSTEM

ABCD Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) ◽

10.1590/0102-672020180001e1385 ◽

2018 ◽

Vol 31 (3) ◽

Cited By ~ 9

Author(s):

Cüneyt KIRKIL ◽

Erhan AYGEN ◽

Mehmet Fatih KORKMAZ ◽

Mehmet Buğra BOZAN

Keyword(s):

Quality Of Life ◽

Weight Loss ◽

Sleeve Gastrectomy ◽

Laparoscopic Sleeve Gastrectomy ◽

Weight Control ◽

Excess Weight ◽

Bariatric Procedure ◽

The Mean ◽

The Impact

ABSTRACT Background: Laparoscopic sleeve gastrectomy (LSG) is currently the most frequently performed bariatric procedure in Turkey. The goal of weight reduction surgery is not only to decrease excess weight, but also to improve obesity related comorbidities and quality of life (QoL). Aim: To evaluate the impact of LSG on patient quality of life, weight loss, and comorbidities associated with morbid obesity according to the updated BAROS criteria. Methods: Eleven hundred thirty-eight adult patients were undergone to LSG by our bariatric surgery team between January 2013 and January 2016. A questionnaire (The Bariatric Analysis and Reporting Outcome System - BAROS) was published on social media. The data on postoperative complications were collected from hospital database. Results: Number of respondants was 562 (49.4%). Six of 1138 patients(0.5%) had leakage. All patients who had leakage were respondants. The overall complication rate was 7.7%. After a mean period of 7.4±5.3 months(1-30), mean excess weight loss was 71.3±27.1% (10.2-155.4). The respondants reported 772 comorbidities. Of these, 162 (30%) were improved, and 420 (54.4%) were resolved. The mean scores for QoL were significantly increased after LSG (range, p<0.05 to <0.001). Of the 562 patients, 26 (4.6%) were classified as failures; 86 (15.3%) fair; 196 (34.9%) good; 144 (25.6%) very good, and 110 (19.6%) excellent results according to the updated BAROS scoring system. Conclusion: LSG is a highly effective bariatric procedure in the manner of weight control, improvement in comorbidities and increasing of QoL in short- and mid-term.

Download Full-text

Dynamics of quality of life in patients with morbid obesity after biliopancreatic diversion and sleeve gastrectomy

Reports of Vinnytsia National Medical University ◽

10.31393/reports-vnmedical-2018-22(3)-32 ◽

2018 ◽

Vol 22 (3) ◽

pp. 548-552

Author(s):

O.V. Perekhrestenko

Keyword(s):

Quality Of Life ◽

Bariatric Surgery ◽

Morbid Obesity ◽

Sleeve Gastrectomy ◽

Surgical Treatment ◽

Biliopancreatic Diversion ◽

Comparison Group ◽

Main Group ◽

The Impact

The rapid progress of obesity surgery dictates the necessity to study the quality of life of patients after bariatric procedures. The aim of the study is to assess the dynamics of quality of life of patients with morbid obesity after biliopancreatic diversion in the modification of Hess-Marceau and the sleeve gastrectomy in order to improve the results of surgical treatment of the specified category of patients. The results of surgical treatment of 205 patients with morbid obesity who performed sleeve gastrectomy (main group — 105 patients) or biliopancreatic diversion by Hess-Marceau (comparison group — 100 patients) were analyzed. The study of the dynamics of quality of life of patients was performed in according the Moorehead-Ardelt II method. Statistical data processing was performed using the methods of variational and descriptive statistic using Statistica 6.0 statistical analysis package. Installed that biliopancreatic diversion by Hess-Marceau and sleeve gastrectomy allowed to significantly improve the quality of life of patients with an increase of the quality of life index with -1.5±0.7 in the comparison group and -1.6±0,6 in the main group up to 1.8±0.3 and 2.0±0.4 respectively (p<0.05 compared to pre-operative data) 60 months after surgery. A more pronounced positive dynamics of quality of life in patients of the main group in the time interval of 12–24 months after the operation was achieved due to the absence of severe late metabolic complications and undesirable side effects of biliopancreatic diversion and laparoscopic access for sleeve gastrectomy in 54.3% of patients. Thus, the quality of life of patients with morbid obesity before performing bariatric surgery is critically low and significantly improved after biliopancreatic diversion by Hess-Marceau as well as sleeve gastrectomy. The impact of bariatric surgery on the duration and quality of life of patients requires further multicenter randomized trials.

Download Full-text

Changes in quality of life 5 years after sleeve gastrectomy: a prospective cohort study

BMJ Open ◽

10.1136/bmjopen-2019-031170 ◽

2019 ◽

Vol 9 (9) ◽

pp. e031170 ◽

Cited By ~ 1

Author(s):

Tone Nygaard Flølo ◽

Grethe S Tell ◽

Ronette L Kolotkin ◽

Anny Aasprang ◽

Tone Merete Norekvål ◽

...

Keyword(s):

Quality Of Life ◽

Bariatric Surgery ◽

Weight Loss ◽

Cohort Study ◽

Sleeve Gastrectomy ◽

Prospective Cohort Study ◽

Prospective Cohort ◽

Short Form

ObjectivesSleeve gastrectomy (SG) is the most frequently performed bariatric surgery procedure worldwide, but reports on long-term quality of life (QOL) outcomes are scarce. We investigated 5-year trajectories in QOL and their associations with weight loss after SG.DesignA prospective cohort study.SettingThe study was conducted in a single Norwegian bariatric surgery centre.ParticipantsOut of 150 operated patients, 127 were included. Mean age was 41 years, 68% were women and the follow-up rate at 1 year was 85% and 64% at 1 and 5 years, respectively.Outcome measuresData were collected preoperatively, and 1 and 5 years after surgery assessing three different levels of QOL. The main exposure was weight loss after SG, assessed as per cent excess body mass index (kg/m2) loss (%EBMIL). The Obesity-Related Problem (OP) scale was used to measure obesity-specific health-related QOL (HRQOL). Physical (PCS) and mental (MCS) composite summary scores of the Short Form 36 Health Survey were used to capture generic HRQOL and Cantril Ladder was used to assess overall QOL.ResultsAll HRQOL/overall QOL measures significantly improved at 1 year, followed by modest decline from 1 to 5 years after surgery. Greater %EBMIL 5 years after surgery was significantly associated with improvements in OP and PCS scores, but not with MCS and Cantril Ladder scores. Although significant (p<0.001) and clinically relevant improvements in HRQOL/overall QOL outcomes were observed at 5 years, scores were still below the general population norms.ConclusionMost patients undergoing SG experience substantial weight loss accompanied by statistically significant and clinically relevant long-term improvements in HRQOL/overall QOL. However, an important minority of patients still report low HRQOL/overall QOL 5 years after SG. Further research should aim to identify other factors that contribute to impaired QOL after bariatric surgery, even in the presence of successful weight control.

Download Full-text

PP012 Efficacy And Safety Of The ELIPSE Gastric Balloon For Weight Loss

International Journal of Technology Assessment in Health Care ◽

10.1017/s0266462318000296 ◽

2017 ◽

Vol 33 (S1) ◽

pp. 72-73

Author(s):

Luis María Sánchez-Gómez ◽

Setefilla Luengo-Matos ◽

Mar Polo-Desantos ◽

Juan Pablo Chalco Orrego

Keyword(s):

Quality Of Life ◽

Weight Loss ◽

New Technologies ◽

Cochrane Library ◽

Gastric Balloon ◽

Efficacy And Safety ◽

Early Assessment ◽

The Mean ◽

The Impact

INTRODUCTION:Conventional gastric balloons for weight loss require endoscopy for placement and removal. The ELIPSETM is a new gastric balloon designed for weight loss that is swallowed and does not require endoscopy or anesthesia. The device is designed to remain in the stomach and be expelled after a predetermined time of 4 months. The objective of this work is to assess the efficacy and safety of the ELIPSETM procedureless gastric balloon for weight loss.METHODS:The ELIPSETM procedureless gastric balloon was identified by the early Awareness and Alert System, “SINTESIS-new technologies,” of The Instituto De Salud Carlos III (AETS-ISCIII). An early assessment of the technology was conducted. The searched databases were: MEDLINE (PubMed), Centre for Reviews and Dissemination, and the Cochrane Library. Clinical studies using the device published in any language until 10 January 2017 were reviewed.RESULTS:A prospective, non-randomized, open label study supported by industry was retrieved. Thirty-four patients were enrolled. Six patients treated with an experimental device were excluded. Twenty-eight patients successfully swallowed the device. No endoscopy or anesthesia was required. All devices were excreted safely. Of the twenty-five patients finally studied, the mean percent total body weight loss was 10 percent (95 percent Confidence Interval, CI 7.3–12.7) and the mean waist circumference was reduced by 8.4cm (95 percent CI 5.7-11.8) at 4 months. Improvements were also seen in metabolic parameters (HbA1c, Low density lipoprotein, triglycerides and blood pressure). All aspects of quality of life measured by the Impact of Weight on Quality of Life (IWQoL) questionnaire demonstrated significant improvements. About safety, there were no serious adverse events or serious adverse device effects, however 64 percent of patients had vomiting, 54 percent experienced nausea, 25 percent had abdominal pain and 2 patients were excluded because of symptoms.CONCLUSIONS:The ELIPSETM gastric balloon for weight loss seems to be an effective therapy with an acceptable safety profile. However it would be necessary to continue further studies to confirm these results, including comparative studies with current treatments.

Download Full-text

The impact of protein support on weight loss, sarcopenia and quality of life after sleeve gastrectomy

Clinical Nutrition ◽

10.1016/j.clnu.2018.06.1145 ◽

2018 ◽

Vol 37 ◽

pp. S26

Author(s):

Y. Güneş ◽

B. Karip ◽

A. Ergin ◽

M.M. Fersahoğlu ◽

N.E. Bulut ◽

...

Keyword(s):

Quality Of Life ◽

Weight Loss ◽

Sleeve Gastrectomy ◽

The Impact

Download Full-text

890 The Impact of Multidisciplinary Evaluation Before and After Endoscopic Sleeve Gastroplasty on Weight Loss and Quality of Life

The American Journal of Gastroenterology ◽

10.14309/01.ajg.0000593096.54600.48 ◽

2019 ◽

Vol 114 (1) ◽

pp. S515-S516

Author(s):

Ivo Boškoski ◽

Vincenzo Bove ◽

Lucrezia Laterza ◽

Camilla Gallo ◽

Rosario Landi ◽

...

Keyword(s):

Quality Of Life ◽

Weight Loss ◽

Endoscopic Sleeve Gastroplasty ◽

Before And After ◽

Sleeve Gastroplasty ◽

The Impact

Download Full-text

FULL-THICKNESS ENDOSCOPIC GASTRIC RESECTION USING A STAPLER AND GASTROSTOMY: A FEASIBILITY STUDY

ABCD Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) ◽

10.1590/0102-672020180001e1386 ◽

2018 ◽

Vol 31 (3) ◽

Author(s):

André M. WADA ◽

Kiyoshi HASHIBA ◽

Jose P. OTOCH ◽

Horus BRASIL ◽

Fernando P. MARSON ◽

...

Keyword(s):

Quality Of Life ◽

Weight Loss ◽

Weight Control ◽

Gastric Resection ◽

Excess Weight Loss ◽

Excess Weight ◽

Bariatric Procedure ◽

The Mean ◽

The Impact

Download Full-text

The Impact of Protein Support on Weight Loss, Sarcopenia, and Quality of Life After Sleeve Gastrectomy

Bariatric Surgical Practice and Patient Care ◽

10.1089/bari.2018.0057 ◽

2019 ◽

Vol 14 (3) ◽

pp. 131-136 ◽

Cited By ~ 1

Author(s):

Yasin Güneş ◽

Bora Karip ◽

Anıl Ergin ◽

Nuriye Esen Bulut ◽

Mehmet Mahir Fersahoğlu ◽

...

Keyword(s):

Quality Of Life ◽

Weight Loss ◽

Sleeve Gastrectomy ◽

The Impact

Download Full-text

Sacral electroacupuncture as a treatment for urge urinary incontinence: a prospective case series

Acupuncture in Medicine ◽

10.1177/0964528420968846 ◽

2020 ◽

pp. 096452842096884

Author(s):

Shan Chen ◽

Siyou Wang ◽

Lihua Xuan ◽

Fu Xu ◽

Hanti Lu ◽

...

Keyword(s):

Quality Of Life ◽

Urinary Incontinence ◽

Case Series ◽

Urge Urinary Incontinence ◽

Life Questionnaire ◽

Improvement Rate ◽

Significant Difference ◽

Before And After ◽

The Impact

Objective: To examine the impact of electroacupuncture (EA) at the ‘four sacral points’ on urge urinary incontinence (UUI). Methods: Twenty-five patients diagnosed with UUI or urgency-predominant mixed urinary incontinence (MUI) were treated by EA at the ‘four sacral points’. EA was performed in the sacrococcygeal region using disposable sterile 0.40-mm-diameter acupuncture needles that were either 100 or 125 mm in length. Treatments were delivered once every other day. Before and after treatment, a questionnaire measuring symptom severity and quality of life associated with UUI was administered. Results: The median total score (interquartile range) from the severity of symptoms and the quality of life questionnaire (Q-score) of the participants was significantly reduced from 12 (7.5, 15) before treatment to 3 (0, 6) after 6 (6, 12) EA treatments. The Q-score of urgency-predominant MUI and UUI was 8 (5, 14.5) and 12.5 (11, 15), respectively, before treatment; after treatment these were reduced to 2 (0, 7.5) and 4.5 (2, 6), respectively. There was no statistically significant difference in the Q-score between urgency-predominant MUI and UUI before and after treatment. Upon treatment completion, seven patients (28%) were ‘cured’ (improvement rate 100%). Treatments were considered ‘markedly effective’ (improvement rate 75% to <100%) in four patients (16%), ‘effective’ (improvement rate 50% to <75%) in eight patients (32%), ‘minimally effective’ (improvement rate 25% to <50%) in three patients (12%), and ‘ineffective’ (improvement rate <25%) in three patients (12%). The overall success rate (comprising ‘cured’, ‘markedly effective’ and ‘effective’ categories) was 76%, and no adverse effects associated with acupuncture treatment were reported. Conclusion: EA at the ‘four sacral points’ was associated with statistically significant improvements in UUI.

Download Full-text

Laparoscopic sleeve gastrectomy as a primary bariatric procedure: postoperative outcomes

Medicine and Pharmacy Reports ◽

10.15386/mpr-1762 ◽

2021 ◽

Author(s):

Flavius Mocian ◽

Marius Coroș

Keyword(s):

Quality Of Life ◽

Weight Loss ◽

Sleeve Gastrectomy ◽

Laparoscopic Sleeve Gastrectomy ◽

Weight Regain ◽

Bariatric Procedure ◽

Obstructive Sleep ◽

The Mean

Background and aims. Laparoscopic sleeve gastrectomy is at present the most popular bariatric procedure due to its significant effect on weight loss, resolution of comorbidities and improvement in the quality of life. However, there are not many studies showing its medium and long term efficacy and safety in Eastern Europe. We aim to report the outcomes of laparoscopic sleeve gastrectomy as a primary bariatric procedure from a single surgical department. Methods. This is a retrospective analysis of obese patients who underwent laparoscopic sleeve gastrectomy between 2009 - 2016 in our department. Outcomes were analyzed in terms of weight loss, comorbidity resolution and quality of life changes. Results. A number of 70 patients were included in the study, with a mean age of 47.6 ± 9.8 years. Mean initial Body Mass Index was 47.4 ± 6.4 kg/m2. The mean percentage of excess weight loss during follow-up was 78.2% at 12 months, 80.2%, 76.7%, 74.7%, 72.8%, 73.3%, 74.1%, 67.2%, 64.07%, 69.7% at 24, 36, 48, 60, 72, 84, 96, 108 and 120 months, respectively. Weight regain occurred in 61 (87.1%) patients during the postoperative period. The mean weight regained was 8.1 ± 4.8 kg at 24 months postoperatively. Regarding the quality of life, 83% of patients declared an increase in self-esteem. Resolution of diabetes, arterial hypertension, and obstructive sleep apnea syndrome occurred in 80%, 42.5% and 70.1% of patients respectively. Conclusions. Laparoscopic sleeve gastrectomy is an effective procedure, with good outcomes in the medium and long term, although a tendency for weight regain was noted after 2 years. Resolution of comorbidities is comparable with that reported in the literature, namely an improvement of the quality of life.

Download Full-text